ARCHIVES

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Clinical Trials Approved By NCI CTEP Last Month

May 27, 2011

HHS Forms Office for Recovery Act

March 13, 2009

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

Post Reporter Responds To Criticism Of Cancer Series

January 1, 1982

FY 2000 Budget: Success Rate Drops Projected, Would Take Years to Catch Up

February 19, 1999